Ingrid Øra

affiliated with the university
More filtering options
  1. 2018
  2. Anti-müllerian hormone compared with other ovarian markers after childhood cancer treatment

    Anna Nyström, Helena Mörse, Nordlöf, H., Wiebe, K., Artman, M., Ingrid Øra, Aleksander Giwercman, Henic, E. & Maria Elfving, 2018 Dec 18, In : Acta Oncologica.

    Research output: Contribution to journalArticle

  3. Four evolutionary trajectories underlie genetic intratumoral variation in childhood cancer

    Jenny Karlsson, Anders Valind, Linda Holmquist Mengelbier, Bredin, S., Louise Cornmark, Jansson, C., Wali, A., Johan Staaf, Viklund, B., Ingrid Øra, Anna Börjesson, Backman, T., Noémie Braekeveldt, Sandstedt, B., Pal, N., Isaksson, A., Lackner, B. G., Tord Jonson, Daniel Bexell & David Gisselsson, 2018 Jul, In : Nature Genetics. 50, 7, p. 944-950

    Research output: Contribution to journalArticle

  4. Genomic Profiles of Neuroblastoma Associated With Opsoclonus Myoclonus Syndrome

    Hero, B., Clement, N., Ingrid Øra, Pierron, G., Lapouble, E., Theissen, J., Pasqualini, C., Valteau-Couanet, D., Plantaz, D., Michon, J., Delattre, O., Tardieu, M. & Schleiermacher, G., 2018, In : Journal of Pediatric Hematology/Oncology. 40, 2, p. 93-98

    Research output: Contribution to journalArticle

  5. High risk of hypogonadism in young male cancer survivors

    S. Isaksson, K. Bogefors, Ståhl, O., J. Eberhard, Y. L. Giwercman, Leijonhufvud, I., Link, K., I. Øra, Romerius, P., Bobjer, J. & A. Giwercman, 2018, In : Clinical Endocrinology. 88, 3, p. 432-441

    Research output: Contribution to journalArticle

  6. Patient-derived xenograft models reveal intratumor heterogeneity and temporal stability in neuroblastoma

    Braekeveldt, N. , Von Stedingk, K. , Fransson, S. , Martinez-Monleon, A. , Lindgren, D. , Axelson, H. , Levander, F. , Willforss, J. , Hansson, K. , Øra, I. , Backman, T. , Börjesson, A. , Beckman, S. , Esfandyari, J. , Berbegall, A. P. , Noguera, R. , Karlsson, J. , Koster, J. , Martinsson, T. , Gisselsson, D. & 2 others Sven Påhlman & Daniel Bexell, 2018, In : Cancer Research. 78, 20, p. 5958-5969 12 p.

    Research output: Contribution to journalArticle

  7. Somatic late effects in 5-year survivors of neuroblastoma: a population-based cohort study within the Adult Life after Childhood Cancer in Scandinavia study

    Norsker, F. N., Rechnitzer, C., Cederkvist, L., Anna Sällfors Holmqvist, Tryggvadottir, L., Madanat-Harjuoja, L. M., Ingrid Øra, Thorarinsdottir, H. K., Vettenranta, K., Bautz, A., Schrøder, H., Hasle, H. & Winther, J. F., 2018, In : International Journal of Cancer. 143, 12, p. 3083-3096

    Research output: Contribution to journalArticle

  8. 2017
  9. Venous thrombosis in children and adolescents with Hodgkin lymphoma in Sweden

    Schönning, A., Karlén, J., Frisk, T., Heyman, M. M., Svahn, J. E., I. Øra, Kawan, L., Holmqvist, B. M., Björklund, C., Harila-Saari, A. & Ranta, S., 2017 Apr 1, In : Thrombosis Research. 152, p. 64-68 5 p.

    Research output: Contribution to journalArticle

  10. 2016
  11. Neuroblastoma patient-derived orthotopic xenografts reflect the microenvironmental hallmarks of aggressive patient tumours

    Noémie Braekeveldt, Caroline Wigerup, Tadeo, I., Beckman, S., Caroline Sandén, Jönsson, J., Jonas S Erjefält, Berbegall, A. P., Anna Börjesson, Backman, T., Ingrid Øra, Navarro, S., Noguera, R., David Gisselsson, Sven Påhlman & Daniel Bexell, 2016, In : Cancer Letters. 375, 2, p. 384-389

    Research output: Contribution to journalArticle

  12. 2015
  13. Omission of doxorubicin from the treatment of stage II-III, intermediate-risk Wilms' tumour (SIOP WT 2001): an open-label, non-inferiority, randomised controlled trial

    SIOP Renal Tumours Study Group, Pritchard-Jones, K., Bergeron, C., de Camargo, B., van den Heuvel-Eibrink, M. M., Acha, T., Godzinski, J., Oldenburger, F., Boccon-Gibod, L., Leuschner, I., Vujanic, G., Sandstedt, B., de Kraker, J., van Tinteren, H., Graf, N. & Ingrid Øra, 2015 Sep 19, In : The Lancet. 386, 9999, p. 1156-64

    Research output: Contribution to journalArticle

  14. Individual patient risk stratification of high-risk neuroblastomas using a two-gene score suited for clinical use.

    Kristoffer von Stedingk, De Preter, K., Vandesompele, J., Noguera, R., Ingrid Øra, Koster, J., Versteeg, R., Sven Påhlman, David Lindgren & Håkan Axelson, 2015, In : International Journal of Cancer. 137, 4, p. 868-877

    Research output: Contribution to journalArticle

  15. Intratumoral genome diversity parallels progression and predicts outcome in pediatric cancer.

    Holmquist Mengelbier, L. , Karlsson, J. , Lindgren, D. , Valind, A. , Lilljebjörn, H. , Jansson, C. , Bexell, D. , Braekeveldt, N. , Ameur, A. , Jonson, T. , Kultima, H. G. , Isaksson, A. , Asmundsson, J. , Versteeg, R. , Rissler, M. , Fioretos, T. , Sandstedt, B. , Börjesson, A. , Backman, T. , Pal, N. & 3 others Ingrid Øra, Mayrhofer, M. & David Gisselsson Nord, 2015, In : Nature Communications. 6, 6125

    Research output: Contribution to journalArticle

  16. MIBG scans in patients with stage 4 neuroblastoma reveal two metastatic patterns, one is associated with MYCN amplification and in MYCN-amplified tumours correlates with a better prognosis

    Bleeker, G., van Eck-Smit, B. L., Zwinderman, K. H., Versteeg, R., van Noesel, M. M., Kam, B. L., Kaspers, G. J., van Schie, A., Kreissman, S. G., Yanik, G., Hero, B., Schmidt, M., Laureys, G., Lambert, B., Ingrid Øra, Schulte, J. H., Caron, H. N. & Tytgat, G. A., 2015, In : European Journal of Nuclear Medicine and Molecular Imaging. 42, 2, p. 222-230

    Research output: Contribution to journalArticle

  17. Neuroblastoma Patient-Derived Orthotopic Xenografts Retain Metastatic Patterns and Geno- and Phenotypes of Patient Tumours.

    Noémie Braekeveldt, Caroline Wigerup, David Gisselsson Nord, Sofie Mohlin, Merselius, M., Beckman, S., Tord Jonson, Anna Börjesson, Backman, T., Tadeo, I., Berbegall, A. P., Ingrid Øra, Navarro, S., Noguera, R., Sven Påhlman & Daniel Bexell, 2015, In : International Journal of Cancer. 136, 5, p. E252-E261

    Research output: Contribution to journalArticle

  18. 2014
  19. A novel SERPINE1-FOSB fusion gene results in transcriptional up-regulation of FOSB in pseudomyogenic haemangioendothelioma.

    Charles Walther, Tayebwa, J., Lilljebjörn, H., Magnusson, L., Nilsson, J., Fredrik Vult von Steyern, Ingrid Øra, Domanski, H., Thoas Fioretos, Karolin Hansén Nord, Fletcher, C. D. & Fredrik Mertens, 2014, In : Journal of Pathology. 232, 5, p. 534-540

    Research output: Contribution to journalArticle

  20. Emergence of New ALK Mutations at Relapse of Neuroblastoma.

    Schleiermacher, G. , Javanmardi, N. , Bernard, V. , Leroy, Q. , Cappo, J. , Rio Frio, T. , Pierron, G. , Lapouble, E. , Combaret, V. , Speleman, F. , de Wilde, B. , Djos, A. , Øra, I. , Hedborg, F. , Träger, C. , Holmqvist, B-M. , Abrahamsson, J. , Peuchmaur, M. , Michon, J. , Janoueix-Lerosey, I. & 3 others Kogner, P., Delattre, O. & Martinsson, T., 2014, In : Journal of Clinical Oncology. 32, 25, p. 2727

    Research output: Contribution to journalArticle

  21. 2013
  22. Acute onset of ovarian dysfunction in young females after start of cancer treatment.

    Helena Mörse, Maria Elfving, Anna Lindgren, Wölner-Hanssen, P., Andersen, C. Y. & Ingrid Øra, 2013, In : Pediatric Blood & Cancer. 60, 4, p. 676-681

    Research output: Contribution to journalArticle

  23. ERBB3 is a marker of a ganglioneuroblastoma/ganglioneuroma-like expression profile in neuroblastic tumours

    Wilzen, A., Krona, C., Sveinbjornsson, B., Kristiansson, E., Dalevi, D., Ingrid Øra, De Preter, K., Stallings, R. L., Maris, J., Versteeg, R., Nilsson, S., Kogner, P. & Abel, F., 2013, In : Molecular Cancer. 12, 70

    Research output: Contribution to journalArticle

  24. Haploidentical stem cell transplantation in two children with mucopolysaccharidosis VI: clinical and biochemical outcome

    Jester, S., Larsson, J., Eklund, E., Papadopoulou, D., Mansson, J-E., Békássy, A., Turkiewicz, D., Toporski, J. & Ingrid Øra, 2013, In : Orphanet Journal of Rare Diseases. 8, 134

    Research output: Contribution to journalArticle

  25. Intratumour diversity of chromosome copy numbers in neuroblastoma mediated by on-going chromosome loss from a polyploid state.

    Lundberg, G., Jin, Y., Sehic, D., Ingrid Øra, Versteeg, R. & David Gisselsson Nord, 2013, In : PLoS ONE. 8, 3, e59268

    Research output: Contribution to journalArticle

  26. snoRNPs Regulate Telomerase Activity in Neuroblastoma and Are Associated with Poor Prognosis.

    Kristoffer von Stedingk, Koster, J., Piqueras, M., Noguera, R., Navarro, S., Sven Påhlman, Versteeg, R., Ingrid Øra, David Gisselsson Nord, David Lindgren & Håkan Axelson, 2013, In : Translational Oncology. 6, 4, p. 447-U142

    Research output: Contribution to journalArticle

  27. 2012
  28. Copy Number Defects of G1-Cell Cycle Genes in Neuroblastoma are Frequent and Correlate with High Expression of E2F Target Genes and a Poor Prognosis

    Molenaar, J. J., Koster, J., Ebus, M. E., van Sluis, P., Westerhout, E. M., de Preter, K., David Gisselsson Nord, Ingrid Øra, Speleman, F., Caron, H. N. & Versteeg, R., 2012, In : Genes, Chromosomes and Cancer. 51, 1, p. 10-19

    Research output: Contribution to journalArticle

  29. Identification of BIRC6 as a novel intervention target for neuroblastoma therapy

    Lamers, F., Schild, L., Koster, J., Speleman, F., Ingrid Øra, Westerhout, E. M., van Sluis, P., Versteeg, R., Caron, H. N. & Molenaar, J. J., 2012, In : BMC Cancer. 12

    Research output: Contribution to journalArticle

  30. Oncogenic activation of FOXR1 by 11q23 intrachromosomal deletion-fusions in neuroblastoma

    Santo, E. E., Ebus, M. E., Koster, J., Schulte, J. H., Lakeman, A., van Sluis, P., Vermeulen, J., David Gisselsson Nord, Ingrid Øra, Lindner, S., Buckley, P. G., Stallings, R. L., Vandesompele, J., Eggert, A., Caron, H. N., Versteeg, R. & Molenaar, J. J., 2012, In : Oncogene. 31, 12, p. 1571-1581

    Research output: Contribution to journalArticle

  31. Sequencing of neuroblastoma identifies chromothripsis and defects in neuritogenesis genes

    Molenaar, J. J. , Koster, J. , Zwijnenburg, D. A. , van Sluis, P. , Valentijn, L. J. , van der Ploeg, I. , Hamdi, M. , van Nes, J. , Westerman, B. A. , van Arkel, J. , Ebus, M. E. , Haneveld, F. , Lakeman, A. , Schild, L. , Molenaar, P. , Stroeken, P. , van Noesel, M. M. , Øra, I. , Santo, E. E. , Caron, H. N. & 2 others Westerhout, E. M. & Versteeg, R., 2012, In : Nature. 483, 7391, p. 589-U107

    Research output: Contribution to journalArticle

  32. Stability of PCR Targets for Monitoring Minimal Residual Disease in Neuroblastoma

    Stutterheim, J., Zappeij-Kannegieter, L., Ingrid Øra, van Sluis, P. G., Bras, J., den Ouden, E., Versteeg, R., Caron, H. N., van der Schoot, C. E. & Tytgat, G. A. M., 2012, In : The Journal Of Molecular Diagnostics. 14, 2, p. 168-175

    Research output: Contribution to journalArticle

  33. Targeted BCL2 inhibition effectively inhibits neuroblastoma tumour growth

    Lamers, F., Schild, L., den Hartog, I. J. M., Ebus, M. E., Westerhout, E. M., Ingrid Øra, Koster, J., Versteeg, R., Caron, H. N. & Molenaar, J. J., 2012, In : European Journal of Cancer. 48, 16, p. 3093-3103

    Research output: Contribution to journalArticle

  34. Tumor-initiating cells in childhood neuroblastoma: Letter

    Sofie Mohlin, Alexander Pietras, Caroline Wigerup, Ingrid Øra, Andäng, M., Nilsson, K., Olofsson, T., David Gisselsson Nord & Sven Påhlman, 2012, In : Cancer Research. 72, 3, p. 821-822

    Research output: Contribution to journalLetter

  35. 2011
  36. Alternative lengthening of telomeres-An enhanced chromosomal instability in aggressive non-MYCN amplified and telomere elongated neuroblastomas.

    Lundberg, G., Sehic, D., Länsberg, J-K., Ingrid Øra, Attila Frigyesi, Castel, V., Navarro, S., Piqueras, M., Martinsson, T., Noguera, R. & David Gisselsson Nord, 2011, In : Genes, Chromosomes and Cancer. 50, 4, p. 250-262

    Research output: Contribution to journalArticle

  37. Incidence and Survival Analyses in Children with Solid Tumours Diagnosed in Sweden 1983-2007.

    Swedish Childhood Solid Tumour Working Group (VSTB), Ljungman, G., Jakobson, A., Behrendtz, M., Ek, T., Friberg, L-G., Hjalmars, U., Lars Hjorth, Lindh, J., Pal, N., Sandstedt, B., Osterlundh, G., Gustafsson, G. & Ingrid Øra, 2011, In : Acta paediatrica. 100, 5, p. 750-757

    Research output: Contribution to journalArticle

  38. Reverse pseudohyperkalemia in heparin plasma samples from a child with T cell acute lymphoblastic leukemia with hyperleukocytosis

    Garwicz, D., Karlman, M. & Ingrid Øra, 2011, In : Clinica Chimica Acta. 412, 3-4, p. 396-397

    Research output: Contribution to journalLetter

  39. 2010
  40. A biology-driven approach identifies the hypoxia gene signature as a predictor of the outcome of neuroblastoma patients.

    Paolo, F., Annalisa, B., Sofia, M., Rosasco, L., Alessandro, V., Rogier, V., Huib N, C., Jan J, M., Ingrid Øra, Alessandra, E., Maura, P. & Luigi, V., 2010, In : Mol Cancer. 12, 9, p. 185-185

    Research output: Contribution to journalArticle

  41. Generation of trisomies in cancer cells by multipolar mitosis and incomplete cytokinesis.

    David Gisselsson Nord, Jin, Y., David Lindgren, Persson, J., Gisselsson, L., Hanks, S., Sehic, D., Linda Holmquist Mengelbier, Ingrid Øra, Rahman, N., Fredrik Mertens, Felix Mitelman & Nils Mandahl, 2010, In : Proceedings of the National Academy of Sciences. 107, 47, p. 20489-20493

    Research output: Contribution to journalArticle

  42. NF1 is a tumor suppressor in neuroblastoma that determines retinoic acid response and disease outcome.

    M, H., S, H., J, K., Ingrid Øra, A, L., H, C., W, N., Jan J, X., T, C., S, A., RC, S., Luigi, M., R, V. & R, B., 2010, In : Cell.. 142, 2, p. 218-229

    Research output: Contribution to journalArticle

  43. 2009
  44. Low frequency of EWSR1 rearrangements in neoplasms classified as high-risk wilms tumors.

    Ildiko Frigyesi, Möller, E., Stewénius, Y., Isaksson, M., Bras, J., Alumets, J., Ingrid Øra, Sandstedt, B. & David Gisselsson Nord, 2009, In : Pediatric Blood & Cancer. 53, p. 683-684

    Research output: Contribution to journalArticle

  45. Lysine-Specific Demethylase 1 Is Strongly Expressed in Poorly Differentiated Neuroblastoma: Implications for Therapy.

    Schulte, J. H., Lim, S., Schramm, A., Friedrichs, N., Koster, J., Versteeg, R., Ingrid Øra, Pajtler, K., Klein-Hitpass, L., Kuhfittig-Kulle, S., Metzger, E., Schüle, R., Eggert, A., Buettner, R. & Kirfel, J., 2009, In : Cancer Research. 69, p. 2065-2071

    Research output: Contribution to journalArticle

  46. Telomere length in neuroblastoma: a prognostic factor?

    Lundberg, G., Ingrid Øra & David Gisselsson Nord, 2009, In : Chromosome Research. 17, p. 116-116

    Research output: Contribution to journalPublished meeting abstract

  47. The low-affinity neurotrophin receptor, p75, is upregulated in ganglioneuroblastoma/ganglioneuroma and reduces tumorigenicity of neuroblastoma cells in vivo

    Schulte, J. H., Pentek, F., Hartmann, W., Schramm, A., Friedrichs, N., Ingrid Øra, Koster, J., Versteeg, R., Kirfel, J., Buettner, R. & Eggert, A., 2009, In : International Journal of Cancer. 124, 10, p. 2488-2494

    Research output: Contribution to journalArticle

Previous 1 2 Next